Agarose Gel Electrophoresis System Market Report 2024

This Agarose Gel Electrophoresis System market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The agarose gel electrophoresis system market size has grown strongly in recent years. It will grow from $3.24 billion in 2023 to $3.51 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth observed in the historic period can be credited to the rising adoption of genetic research and genomics, an increasing demand for personalized medicine and targeted therapies, the expansion of academic and research institutions concentrating on molecular biology, advancements in gel electrophoresis technology that have improved resolution and sensitivity, and the growth of the biopharmaceutical and biotechnology industries.

The agarose gel electrophoresis system market size is expected to see strong growth in the next few years. It will grow to $4.83 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth during the forecast period can be attributed to the ongoing expansion of genomic and proteomic research, a rising prevalence of chronic diseases requiring advanced diagnostics, increased emphasis on precision medicine and personalized healthcare solutions, growth in research activities within emerging markets, and an increase in research funding from both academic and private sectors. Key trends expected during this period include the integration of artificial intelligence and machine learning, the development of high-throughput agarose gel electrophoresis systems, the emergence of miniaturized and portable electrophoresis devices, advancements in automation and robotics, the utilization of real-time imaging and analysis technologies, the adoption of advanced agarose formulations, and the growing incorporation of multiplexing capabilities.

The increasing emphasis on personalized medicine is expected to significantly drive the expansion of the agarose gel electrophoresis system market. Personalized medicine involves customizing medical treatments and healthcare strategies based on an individual's unique genetic makeup, environmental factors, and lifestyle. The growing demand for personalized medicine is fueled by its potential to enhance treatment effectiveness, improve drug efficacy, reduce adverse effects, and offer targeted therapies tailored to individual genetic profiles. Agarose gel electrophoresis plays a critical role in personalized medicine by facilitating the separation and analysis of DNA fragments, supporting genetic testing, and identifying specific genetic variations crucial for individual treatments. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a significant increase from six in 2022. Consequently, the rising focus on personalized medicine is expected to bolster the growth of the agarose gel electrophoresis system market.

The rising prevalence of genetic disorders is anticipated to drive the expansion of the agarose gel electrophoresis system market in the coming years. Genetic disorders, which are caused by abnormalities in an individual's DNA or chromosomes, are becoming increasingly common due to heightened awareness, advancements in diagnostic technologies, and improved reporting. Additional factors include environmental influences and the accumulation of genetic mutations over time. Agarose gel electrophoresis is widely used in the study of genetic disorders by enabling the separation and analysis of DNA fragments, which helps detect genetic mutations, variations, and abnormalities essential for diagnosis or further insight into these conditions. For instance, in March 2024, Gene People, a UK-based charity dedicated to supporting individuals with genetic disorders, reported the existence of over 6,000 genetic conditions, with new ones being discovered daily. In the UK, 1 in 25 children is affected, resulting in 30,000 new diagnoses annually and over 2.4 million people living with genetic conditions. Therefore, the increasing prevalence of genetic disorders is expected to drive demand for agarose gel electrophoresis systems.

Leading companies in the agarose gel electrophoresis system market are increasingly focused on developing advanced solutions such as high-performance and high-resolution gel imaging systems to improve accuracy, efficiency, and research capabilities. High-performance and high-resolution gel imaging systems are designed to capture detailed, clear, and accurate images of gel electrophoresis results, allowing precise visualization of bands and accurate quantification of nucleic acids or proteins with minimal distortion and high sensitivity. For example, in December 2023, Transgen Biotech Co. Ltd., a biotechnology research company based in China, introduced the TSE-N multi-purpose horizontal electrophoresis system and the TSI-100 gel imaging system. These new systems provide enhanced capabilities for agarose gel electrophoresis, offering precise electrophoresis performance and high-resolution gel imaging, which significantly improves accuracy and efficiency in molecular biology research. These systems are equipped with both white light and ultraviolet light sources, enabling digital image processing of gels stained with silver, fluorescent, film, Coomassie brilliant blue, and nucleic acid dyes.

Major companies operating in the agarose gel electrophoresis system market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd, Agilent Technologies Inc., Kaneka Corporation, VWR International, Beckman Coulter Inc, PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, Analytik Jena, Sebia Group, Major Science Co. Ltd., Biocompare Inc., Geno Technology Inc., Cleaver Scientific Ltd., IBI Scientific, C.B.S. Scientific Company, DH Life Sciences LLC., Hoefer Inc., Roylab Pte Ltd.

North America was the largest region in the agarose gel electrophoresis system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the agarose gel electrophoresis system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the agarose gel electrophoresis system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An agarose gel electrophoresis system is a method used to separate DNA, RNA, or proteins based on their size and charge. This process works by applying an electric field to a gel matrix composed of agarose, which causes the molecules to migrate through the gel. Smaller molecules move more quickly and travel further than larger ones, enabling their separation and subsequent analysis.

The primary types of agarose gel electrophoresis systems include tray style, tape style, and dam style. A tray-style system consists of a flat, open tray where the agarose gel is positioned to facilitate the separation of DNA, RNA, or proteins. It accommodates various gel types, such as pourable agarose gel and precast agarose gel, and is utilized in testing centers, laboratories, and other settings.

The agarose gel electrophoresis system market research report is one of a series of new reports that provides agarose gel electrophoresis system market statistics, including the agarose gel electrophoresis system industry's global market size, regional shares, competitors with an agarose gel electrophoresis system market share, detailed agarose gel electrophoresis system market segments, market trends and opportunities, and any further data you may need to thrive in the agarose gel electrophoresis system industry. This agarose gel electrophoresis system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The agarose gel electrophoresis system market consists of sales of agarose gels, electrophoresis power supplies, gel casting trays, gel documentation systems, gel electrophoresis tanks, electrophoresis buffers, gel loading pipettes, and gel extraction kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.